B. Zierfuss

发表

Thrombospondin-4 increases with the severity of peripheral arterial disease and is associated with diabetes

R. Koppensteiner, B. Zierfuss, Clemens Höbaus, 2019, Heart and Vessels.

Angiogenin—A Proposed Biomarker for Cardiovascular Disease—Is Not Associated With Long-Term Survival in Patients With Peripheral Artery Disease

R. Koppensteiner, B. Zierfuss, Clemens Höbaus, 2021, Angiology.

The peripheral perfusion between two extremes: Is a fraction of the pulse wave enough information?

B. Zierfuss, Clemens Höbaus, G. Schernthaner, 2020, Atherosclerosis.

Predictive power of novel and established obesity indices for outcome in PAD during a five-year follow-up.

R. Koppensteiner, B. Zierfuss, Clemens Höbaus, 2020, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Finally, the big picture of morbidity and mortality in peripheral arterial disease?

M. Catalano, B. Zierfuss, G. Schernthaner, 2019, Atherosclerosis.

Galectin-3 is linked to peripheral artery disease severity, and urinary excretion is associated with long-term mortality

R. Koppensteiner, B. Zierfuss, Clemens Höbaus, 2021, Atherosclerosis.

GlycA for long-term outcome in T2DM secondary prevention.

R. Koppensteiner, B. Zierfuss, Clemens Höbaus, 2020, Diabetes research and clinical practice.

Gestational diabetes and maternal obesity suggestively priming children's premature atherosclerosis: Is it the mother fault?

B. Zierfuss, G. Schernthaner, B. Rami-Merhar, 2019, Atherosclerosis.

Lipoprotein (a) and long-term outcome in patients with peripheral artery disease undergoing revascularization.

R. Koppensteiner, B. Zierfuss, Clemens Höbaus, 2022, Atherosclerosis.

New horizons for mortality risk stratification in PAD: Are targeted multiplex proteomics the next step?

C. Neumayer, B. Zierfuss, G. Schernthaner, 2020, Atherosclerosis.

Peripheral artery disease and depression: Prerequisites for a lose-lose situation?

L. Norgren, B. Zierfuss, G. Schernthaner, 2021, Atherosclerosis.